Correction: Antibiotics and probiotics in inflammatory bowel disease: when to use them?

B. Abraham; E. M.M. Quigley

doi:10.1136/flgastro-2018-101057corr1

Correction: Antibiotics and probiotics in inflammatory bowel disease: when to use them?

Research output: Contribution to journal › Comment/debate › peer-review

Abstract

A number of studies cited in this paper assessed a probiotic formulation previously known as VSL#3. The probiotic formulation that was assessed in these studies is now known by the generic name 'De Simone Formulation'. The current product known as VSL#3 is not the same formulation as the De Simone Formulation. The De Simone Formulation is available under the brand names Visbiome (USA) and Vivomixx (Europe). doi: 10.1136/flgastro-2018-100617.

Original language	English (US)
Pages (from-to)	E1
Journal	Frontline Gastroenterology
Volume	11
Issue number	3
DOIs	https://doi.org/10.1136/flgastro-2018-101057corr1
State	Published - May 1 2020

ASJC Scopus subject areas

Hepatology
Gastroenterology

Divisions

Gastroenterology and Hepatology

Access to Document

10.1136/flgastro-2018-101057corr1

Cite this

@article{a96dc9da8dec41109ab5a257477d39fc,

title = "Correction: Antibiotics and probiotics in inflammatory bowel disease: when to use them?",

abstract = "A number of studies cited in this paper assessed a probiotic formulation previously known as VSL\#3. The probiotic formulation that was assessed in these studies is now known by the generic name 'De Simone Formulation'. The current product known as VSL\#3 is not the same formulation as the De Simone Formulation. The De Simone Formulation is available under the brand names Visbiome (USA) and Vivomixx (Europe). doi: 10.1136/flgastro-2018-100617.",

author = "B. Abraham and Quigley, \{E. M.M.\}",

note = "{\textcopyright} Author(s) (or their employer(s)) 2020. No commercial re-use. See rights and permissions. Published by BMJ.",

year = "2020",

month = may,

day = "1",

doi = "10.1136/flgastro-2018-101057corr1",

language = "English (US)",

volume = "11",

pages = "E1",

journal = "Frontline Gastroenterology",

issn = "2041-4137",

publisher = "BMJ Publishing Group",

number = "3",

}

TY - JOUR

T1 - Correction

T2 - Antibiotics and probiotics in inflammatory bowel disease: when to use them?

AU - Abraham, B.

AU - Quigley, E. M.M.

N1 - © Author(s) (or their employer(s)) 2020. No commercial re-use. See rights and permissions. Published by BMJ.

PY - 2020/5/1

Y1 - 2020/5/1

N2 - A number of studies cited in this paper assessed a probiotic formulation previously known as VSL#3. The probiotic formulation that was assessed in these studies is now known by the generic name 'De Simone Formulation'. The current product known as VSL#3 is not the same formulation as the De Simone Formulation. The De Simone Formulation is available under the brand names Visbiome (USA) and Vivomixx (Europe). doi: 10.1136/flgastro-2018-100617.

AB - A number of studies cited in this paper assessed a probiotic formulation previously known as VSL#3. The probiotic formulation that was assessed in these studies is now known by the generic name 'De Simone Formulation'. The current product known as VSL#3 is not the same formulation as the De Simone Formulation. The De Simone Formulation is available under the brand names Visbiome (USA) and Vivomixx (Europe). doi: 10.1136/flgastro-2018-100617.

UR - https://www.scopus.com/pages/publications/85083500719

UR - https://www.scopus.com/inward/citedby.url?scp=85083500719&partnerID=8YFLogxK

U2 - 10.1136/flgastro-2018-101057corr1

DO - 10.1136/flgastro-2018-101057corr1

M3 - Comment/debate

C2 - 32419919

AN - SCOPUS:85083500719

SN - 2041-4137

VL - 11

SP - E1

JO - Frontline Gastroenterology

JF - Frontline Gastroenterology

IS - 3

ER -

Correction: Antibiotics and probiotics in inflammatory bowel disease: when to use them?

Abstract

ASJC Scopus subject areas

Divisions

Access to Document

Other files and links

Fingerprint

Cite this